RT Journal Article
SR Electronic
T1 Switching from originator biological agents to biosimilars: what is the evidence and what are the issues?
JF RMD Open
JO RMD Open
FD EULAR
SP e000492
DO 10.1136/rmdopen-2017-000492
VO 3
IS 2
A1 Eric Toussirot
A1 Hubert Marotte
YR 2017
UL http://rmdopen.bmj.com/content/3/2/e000492.abstract
AB